Pliant Therapeutics Inc

NASDAQ:PLRX   4:00:00 PM EDT
27.52
-0.13 (-0.47%)
5:04:12 PM EDT: $27.52 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.62B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.32 Million
Adjusted EPS-$0.67
See more estimates
10-Day MA$28.31
50-Day MA$29.57
200-Day MA$21.17
See more pivots

Pliant Therapeutics Inc Stock, NASDAQ:PLRX

260 Littlefield Avenue, South San Francisco, California 94080
United States of America
Phone: +1.650.481.6770
Number of Employees: 124

Description

Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-??1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.